Skip to content

BAUSCH & LOMB PHARMA: what changed

BE 0439.621.618NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€871,860
2024 · €1.0m-€131,086
Equity
€751,241
2024 · €751,241
Cash
€996,878
2024 · €761,147+€235,731
Balance sheet total
€9.2m
2024 · €8.1m+€1.1m

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€689,892

    up €689,892 (+10.3%), from €6.7m to €7.4m

    of which Trade receivables: +€640,025

  • Tangible fixed assets +€299,201

    up €299,201 (+226%), from €132,680 to €431,881

  • Cash +€235,731

    up €235,731 (+31.0%), from €761,147 to €996,878

    mainly Trade debts (+€1.4m) and Net result for the year (+€871,860)

  • Stocks and contracts -€154,734

    down €154,734 (-52.4%), from €295,392 to €140,657

Equity and liabilities
  • Trade debts +€1.4m

    up €1.4m (+25.8%), from €5.6m to €7.0m

  • Tax, wage and social debts -€151,619

    down €151,619 (-24.1%), from €628,932 to €477,314

    of which Taxes: -€158,206

  • Other debts -€131,086

    down €131,086 (-13.1%), from €1.0m to €871,860

  • Short-term financial debts -€125,327

    no longer reported in 2025; in 2024 it stood at €125,327

Income statement
  • Turnover +€1.7m

    up €1.7m (+4.7%), from €35.7m to €37.4m

  • Goods and materials +€1.6m

    up €1.6m (+5.7%), from €28.3m to €29.9m

    of which Purchases: +€1.4m

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €1.0m
Turnover +€1.7m
Goods and materials -€1.6m
Services and other goods -€215,007
Staff costs +€85,959
Depreciation -€44,890
Write-downs -€5,483
Provisions -€207,652
Other operating charges +€98,199
Financial income -€725
Financial charges +€8,400
Taxes +€58,936
Result 2025 €871,860
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€1.6m
Investment -€405,047
Financing -€997,187
Cash 2024 €761,147
Net result for the year +€871,860
Depreciation +€136,014
Stocks and contracts +€154,734
Receivables within one year -€689,892
Deferred charges and accrued income -€54,120
Provisions +€70,201
Trade debts +€1.4m
Tax, wage and social debts -€151,619
Other debts -€131,086
Accrued charges and deferred income -€3,103
Investment in fixed assets (net) -€405,047
Short-term financial debts -€125,327
Contributions, distributions and other -€871,860
Cash 2025 €996,878
brings cash intakes cash out
Every line side by side 60 lines
Line Code 2024 2025 Change %
Total assets 20/58 €8,074,541 €9,168,584 +€1.1m +13.5%
Fixed assets 21/28 €283,517 €552,550 +€269,034 +94.9%
Intangible fixed assets 21 €150,836 €120,669 -€30,167 -20.0%
Tangible fixed assets 22/27 €132,680 €431,881 +€299,201 +226%
Other tangible fixed assets 26 €132,680 €431,881 +€299,201 +226%
Current assets 29/58 €7,791,024 €8,616,034 +€825,010 +10.6%
Stocks and contracts in progress 3 €295,392 €140,657 -€154,734 -52.4%
Stocks 30/36 €295,392 €140,657 -€154,734 -52.4%
Goods purchased for resale 34 €295,392 €140,657 -€154,734 -52.4%
Amounts receivable within one year 40/41 €6,714,586 €7,404,478 +€689,892 +10.3%
Trade receivables 40 €6,714,586 €7,354,611 +€640,025 +9.5%
Other amounts receivable 41 - €49,867 +€49,867
Cash at bank and in hand 54/58 €761,147 €996,878 +€235,731 +31.0%
Deferred charges and accrued income 490/1 €19,900 €74,020 +€54,120 +272%
Total equity and liabilities 10/49 €8,074,541 €9,168,584 +€1.1m +13.5%
Equity 10/15 €751,241 €751,241 = 0.0%
Contributions 10/11 €682,947 €682,947 = 0.0%
Capital 10 €682,947 €682,947 = 0.0%
Issued capital 100 €682,947 €682,947 = 0.0%
Reserves 13 €68,295 €68,295 = 0.0%
Non-distributable reserves 130/1 €68,295 €68,295 = 0.0%
Legal reserve 130 €68,295 €68,295 = 0.0%
Provisions and deferred taxes 16 - €70,201 +€70,201
Provisions for liabilities and charges 160/5 - €70,201 +€70,201
Other liabilities and charges 164/5 - €70,201 +€70,201
Amounts payable 17/49 €7,323,300 €8,347,142 +€1.0m +14.0%
Amounts payable within one year 42/48 €7,318,596 €8,345,541 +€1.0m +14.0%
Financial debts 43 €125,327 - -€125,327
Credit institutions 430/8 €125,327 - -€125,327
Trade debts 44 €5,561,390 €6,996,367 +€1.4m +25.8%
Suppliers 440/4 €5,561,390 €6,996,367 +€1.4m +25.8%
Taxes, remuneration and social security 45 €628,932 €477,314 -€151,619 -24.1%
Taxes 450/3 €362,528 €204,322 -€158,206 -43.6%
Remuneration and social security 454/9 €266,404 €272,992 +€6,587 +2.5%
Other amounts payable 47/48 €1,002,946 €871,860 -€131,086 -13.1%
Accrued charges and deferred income 492/3 €4,704 €1,601 -€3,103 -66.0%
Operating income 70/76A €35,712,415 €37,404,611 +€1.7m +4.7%
Turnover 70 €35,712,415 €37,404,611 +€1.7m +4.7%
Operating charges 60/66A €34,351,588 €36,241,480 +€1.9m +5.5%
Goods for resale, raw materials and consumables 60 €28,311,726 €29,912,743 +€1.6m +5.7%
Purchases 600/8 €28,320,563 €29,758,009 +€1.4m +5.1%
Change in stocks: decrease (increase) 609 -€8,838 €154,734 +€163,572
Services and other goods 61 €4,392,505 €4,607,512 +€215,007 +4.9%
Remuneration, social security and pensions 62 €1,520,796 €1,434,837 -€85,959 -5.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €91,123 €136,014 +€44,890 +49.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€1,752 €3,731 +€5,483
Provisions for liabilities and charges: additions (uses and reversals) 635/8 -€137,451 €70,201 +€207,652
Other operating charges 640/8 €174,643 €76,444 -€98,199 -56.2%
Operating profit (loss) 9901 €1,360,827 €1,163,131 -€197,696 -14.5%
Financial income 75/76B €32,244 €31,519 -€725 -2.2%
Recurring financial income 75 €32,244 €31,519 -€725 -2.2%
Other financial income 752/9 €32,244 €31,519 -€725 -2.2%
Financial charges 65/66B €11,056 €2,656 -€8,400 -76.0%
Recurring financial charges 65 €11,056 €2,656 -€8,400 -76.0%
Other financial charges 652/9 €11,056 €2,656 -€8,400 -76.0%
Profit (loss) for the period before taxes 9903 €1,382,015 €1,191,993 -€190,022 -13.7%
Income taxes 67/77 €379,069 €320,133 -€58,936 -15.5%
Taxes 670/3 €379,069 €320,133 -€58,936 -15.5%
Profit (loss) for the period 9904 €1,002,946 €871,860 -€131,086 -13.1%
Profit (loss) for the period to be appropriated 9905 €1,002,946 €871,860 -€131,086 -13.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€3.4m to €4.6m

Midpoint €3.9m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €630,572
Capitalised earnings €6.1m to €8.6m
Indication €3.4m to €4.6m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€751,241
Intangible fixed assets (21)
-€120,669
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€630,572

Capitalised earnings

net result for the year (9904)
2025
€871,860
2024
€1,002,946
2023
€693,191
2022
€449,627
2021
€738,304
Average result
€855,999
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€6.1m / €7.1m / €8.6m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.